If you are searching for the cheapest Mounjaro 7.5mg in the UK, this weight loss injection does not have one fixed lowest price, and 7.5mg will usually cost more than 5mg, so the real comparison is the total cost across providers for the medication, consultation, dose-review fees, needles, and delivery.
You are probably either already on treatment and approaching a dose increase, or comparing pharmacies before starting private treatment. For UK adults seeking prescription access to Mounjaro treatment for weight management, that difference matters because it affects what you can realistically budget for each step of dose escalation, whether you can keep supply consistent, and whether you avoid unlicensed or poorly handled medicines.
This guide breaks down Mounjaro pricing by dose strength, why prices rise as doses increase, what causes pharmacy-to-pharmacy cost differences, and what to check in a proper Mounjaro price comparison UK before you choose a provider. It also covers supply and delivery issues, clinical prescribing requirements for this weight loss injection, NHS access versus private treatment, and the safety checks that help you choose a reliable UK pharmacy with appropriate clinical oversight and storage standards.
What Mounjaro Is and How It's Used for Weight Loss
Mounjaro tirzepatide is the brand name for this medicine, manufactured by Eli Lilly. It is a dual GIP and GLP-1 receptor agonist, and if you are asking how Mounjaro works, it acts on two gut hormone pathways that influence appetite signalling, gastric emptying and blood sugar regulation. It is given as a once-weekly injection using a pre-filled pen.
It holds MHRA marketing authorisation for mounjaro for weight loss alongside diet and exercise, and separately for type 2 diabetes. Every strength is a prescription only medication and requires assessment by a qualified prescriber. Treatment suitability depends on individual clinical assessment.
How the Dose Range and Maintenance Dose Work
Mounjaro is supplied in a range of strengths. Treatment starts at 2.5 mg for the first four weeks and is then increased in steps if tolerated and clinically appropriate, under prescriber supervision.
The important point for anyone comparing prices: 5mg and 7.5mg are usually steps rather than destinations. Most people reach 7.5mg through weekly doses supplied by a mounjaro pen, so these strengths are often part of titration rather than the end goal. Your prescriber determines whether to increase, hold or reduce your dose based on how you are responding and tolerating treatment, and there is no single correct endpoint.
This medicine should only be used under the supervision of an appropriately qualified prescriber, and dose decisions are theirs to make, although some people may later stay on a maintenance dose depending on response and tolerability. What follows is about cost, not about what dose you should be on.
Why Price Rises With Dose Strength
Higher strengths cost pharmacies more to buy, and that flows through to what you pay. The pattern across UK providers is consistent even though the figures differ.
| Position in treatment | What is happening | Cost direction |
|---|---|---|
| Lowest strength | Starting point for everyone | Lowest |
| 5mg | Early step for most people | Rising |
| 7.5mg | Mid-range step | Higher |
| Higher strengths | Where many people settle as the maintenance dose in ongoing treatment | Highest |
The maximum maintenance dose depends on your prescriber's assessment and how you respond to treatment.
Comparing providers based only on your current dose does not give the full picture. A provider who is cheapest at 5mg may not be cheapest at 7.5mg or above, and how long you stay at a given strength under supervision can also depend on factors such as progress, tolerance, and whether you have reached your goal weight.
Mounjaro Price Comparison UK: The Comparison Most Price Pages Skip
Ask any provider for their price at every strength they supply, not just yours. Then compare the total across the range you are likely to move through, and particularly at the higher strengths where you may spend the longest.
What Else Affects What You Pay
Two providers quoting the same figure for 7.5mg can still cost very different amounts over a year.
In the UK, mounjaro cost can run from about £120 to £340 per month, with the 2.5mg starter dose often falling around £120 to £220.
Consultation. Some prices include the initial assessment, some charge separately.
Dose-change review. Increasing a dose requires prescriber review. Some providers include this, others charge each time. If you escalate several times, that adds up.
Needles and sharps disposal. Small individually, meaningful annually.
Delivery. Temperature-controlled shipping costs more than standard post, and it matters for a medicine requiring refrigeration. Most online pharmacies offer first-order discounts for new customers, but compare the full-year total because annual savings can reach about £1,200.
Whether the quoted figure is per pen or per month. Confirm how many doses the price covers, for example, a 7.5mg Mounjaro pen or KwikPen in the UK is typically around £209 to £260, with cheaper 7.5mg options often landing between £209.99 and £265.99.
Why Prices Differ Between UK Pharmacies
Legitimate reasons exist. Pharmacies buy on different volumes and supplier terms. Service models differ, and a price including prescriber time, follow-up review and cold-chain delivery costs more to deliver than medicine-only supply. Some providers price lower strengths keenly and recover margin higher up the range.
What does not vary is the product. Tirzepatide is under patent, there is no generic, and every UK pharmacy buys the same licensed Mounjaro through the same regulated supply chain. Genuine prices therefore cluster within a fairly narrow band. Wholesale changes can still shift retail pricing across providers, including when Eli Lilly raised wholesale prices by up to 170% in September 2025\.
Anything far below that band is not a licensed Mounjaro. Products sold as cheap tirzepatide, as peptides, in multi-dose vials, or in strengths Mounjaro is not supplied in, sit outside the regulated supply chain. Buying weight loss medication or prescription medication outside regulated channels carries a counterfeit risk, so only purchase from GPhC-registered pharmacies to avoid counterfeit products. Contents are unverified, there is no prescriber oversight, and users are typically left measuring their own doses. The MHRA has warned about unlicensed weight-loss products sold online.
Verifying a provider
- GPhC-registered with the General Pharmaceutical Council, with a number you can check on the GPhC-register.
- A genuine clinical assessment, not a checkbox form.
- A named prescriber accountable for the decision.
- UK-based with a physical address.
- Never supply Mounjaro without a prescription, because it is a prescription medicine and a prescription only medicine in the UK.
- Published refund and cancellation terms.
A low price from an unverified source is not a saving.
Supply and Continuity Between Doses
Availability of GLP-1 medicines has fluctuated since launch, with demand repeatedly exceeding manufacturing capacity. Individual strengths have been intermittently constrained, which matters more when you are moving between them. Short gaps can disrupt a broader weight loss treatment plan, not just the next dose.
If your provider cannot supply the strength above yours when your prescriber approves an increase, you face either a wait or a switch. Interruptions to treatment can mean restarting at a lower dose under prescriber guidance, which costs both time and money and can slow your wider weight loss journey.
Before choosing a provider based on price, ask how they manage medicine shortages and supply delays. DHSC and NHS England issue Medicine Supply Notifications when significant supply disruptions are expected, helping healthcare professionals manage shortages.
Storage and Delivery
Mounjaro requires refrigerated storage. The specific range, the permitted time outside the fridge, and in-use limits after first use are set out in the Summary of Product Characteristics. Each mounjaro injection should be used exactly as prescribed, when you inject mounjaro, it is typically into the abdomen or upper thigh. Do not freeze it, and do not use a pen that has frozen.
This is why the delivery method belongs in any price comparison. A pen shipped in ordinary packaging during warm weather may have gone outside its storage range with no visible sign, and the saving on postage is not worth an unusable pen. Ask how a provider ships and what happens if a delivery is delayed or arrives warm. Rotate the injection site each week, as reactions such as swelling or soreness can happen.
The Clinical Evidence
Cost only means something against what the treatment does. Two things follow for anyone comparing dose prices. First, the dose-response relationship in the trials is part of why prescribers escalate, so budgeting only for your current strength is unrealistic. Second, treatment is generally sustained rather than a short course, so annual cost across the range is the meaningful unit.
In the SURMOUNT-1 clinical trials, patients were followed for 72 weeks, with average weight loss of up to 22.5% and up to 57% losing at least 20% of body weight, which helps explain why people compare long-term value rather than a single month's spend. Results vary between individuals, but these findings demonstrate the potential for significant weight loss.
NHS Access
If you qualify, the NHS is the cheapest route at any strength.
NICE recommends tirzepatide for managing overweight and obesity within specific criteria. NHS England introduced access through a phased rollout that prioritises people with the highest clinical need. Because access is being introduced in stages, many people currently receive treatment through private providers.
| NHS | Private | |
|---|---|---|
| Cost | Prescription charge, or free if exempt | Full price at each strength |
| Eligibility | NICE criteria, with phased access typically starting at BMI 40+ plus four comorbidities, with lower thresholds such as 37.5+ for certain ethnic groups | Provider assessment |
| Access | Phased rollout, wait is common | Usually days |
In England, NHS patients usually pay the standard £9.90 prescription charge unless exempt.
Worth asking your GP before assuming private is the only route. NHS weight management resources are free and worth using alongside treatment, since the trial evidence reflects medication delivered with dietary and activity support.
Eligibility
Prescribers assess against criteria typically including body mass index thresholds, with Mounjaro requiring a BMI of at least 30, or 27+ with a weight related health condition such as high blood pressure, alongside other weight related health issues, medical history, current medications and previous weight management attempts. This applies at every dose increase as well as at the start.
Some conditions and circumstances mean tirzepatide is not appropriate. Mounjaro is not suitable for pregnant or breastfeeding individuals. Identifying those is what the assessment exists for, which is why full disclosure matters more than approval. Being declined, at the outset or at a dose review, means a clinician found something making the treatment or the increase unsuitable, including issues linked to other medicines such as current diabetes medications or broader weight related health risks.
